While increased infiltration of FasL+ NK cells represents an increased capacity for NK cell mediated tumor lysis in 177Lu-DOTATATE treated mice, an increased Fas expression by target tumor cells represents increased susceptibility to NK and CD8+ T cell FasL mediated cytotoxic killing [16]. This evidence concerns the gene FAS and neoplasm.